I'll reference you to flipper's posts. The trial is set up to meet this endpoint very well. And as Linda said in the conference, if we meet this EP we'll do so with a p-value of .01 of which only .05 is required.
Feel free, all, to correct if wrong. Wromg has happened to me once or twice.
Other trials had OS as primary EP and only one had better PFS than us. But a lot could've gone into that. Aside from that one, were leaps and bounds ahead.
News 
Market Data 
Discover 
AI
